Maculopathy is relatively common in diabetics, particularly those with type II disease. 1 Macular laser treatment has been shown to preserve the acuity of many of these patients.2 At present any patient who has had laser treatment in both eyes is required by the Driver and Vehicle Licensing Agency (DVLA) of the UK to undergo a binocular field test. 3 Whilst it is well known that patients who have had bilateral pametinal photocoagulation (PRP) may fail such a test, 4-6 and bilateral paracentral scotomata following macular laser treatment can cause a failure, 6 no case series of patients who have undergone macular treatment without PRP has, to our knowledge, been studied.
Maculopathy is relatively common in diabetics, particularly those with type II disease. 1 Macular laser treatment has been shown to preserve the acuity of many of these patients.2 At present any patient who has had laser treatment in both eyes is required by the Driver and Vehicle Licensing Agency (DVLA) of the UK to undergo a binocular field test. 3 Whilst it is well known that patients who have had bilateral pametinal photocoagulation (PRP) may fail such a test, 4-6 and bilateral paracentral scotomata following macular laser treatment can cause a failure, 6 no case series of patients who have undergone macular treatment without PRP has, to our knowledge, been studied.
The purpose of this study was to ascertain the frequency and reasons for any failure of binocular driving fields after bilateral macular laser treatment performed according to a set protocol by a team working in a diabetic retinal clinic.
Patients and methods
The patients who had undergone bilateral macular laser treatment, but no PRP, under a single consultant's care between April 1994 and April 1998 were identified from the laser register and their case notes subjected to study.
In cases where the binocular visual acuity was not recorded in the case notes, patients with a monocular best corrected visual acuity of 6/12 or better in each eye of 6/9 or better in one eye at the last clinic visit were included. These patients were included because they were likely to pass the visual acuity criteria for driving set by DVLA. (In the clinic situation this translates to a binocular Snellen visual acuity of 6/10 or better in the best possible lighting.)
Macular laser was defined here as argon retinal laser photocoagulation applied to areas within a disc diameter from the centre of the fovea and possibly outside this area but not anywhere peripheral to the temporal arcades. This may be photocoagulation of microaneurysms or grid laser treatment to areas of retinal oedema or both. Grid laser involves spacing burns about one burn apart over oedematous retina and bums over microaneurysms may be repeated to achieve blanching whenever necessary. Since all the patients in this study were treated in the same consultant team a uniform strategy was adopted for treatment. In particular we have a policy not to perform confluent ablative treatment. All the patients were treated using an argon laser with a fundus contact lens which does not significantly magnify the spot size of the laser beam. The indications for treatment were defined by the EDTRS criteria? Retreatment was allowable when considered necessary. The total number of bums applied, the duration of exposure of each bum, spot size and power setting were recorded on a database.
Any patients not passing the visual acuity criteria set of DVLA (as defined above) were noted. The results of the Esterman driving visual field assessment done on those patients who had already performed it were noted. The remaining patients who for any reason had not had the test were contacted and requested to perform it following suitable explanation.
The records of patients who declined to attend were examined and their laser details compared with all those who had performed the test.
All binocular driving visual field tests were performed with the Humphrey field analyser using a 121 point Esterman strategy. Points considered relevant extend over a horizontal extent of 120° and 40° vertically centred on fixation. Standard settings for the DVLA test were employed. No optical correction was used during the test, as is usual practice in our unit. The test was performed once and patients recording a marginal failure (defined as one missed point within the field of interest defined above) underwent a repeat test.
We defined a pass as a positive response to all Humphrey targets within the 120° x 40° area marked on Fig. 1 . For the purposes of this study any missed point(s) within this zone constituted a failure (allowing a repeat test for one missed point as described above).
Results
One hundred and thirty-eight patients had had bilateral laser therapy for diabetic maculopathy (without PRP) during the 4 year study period. Fifty-four patients were not eligible (24 had died during the study period, 21 patients were excluded because of poor acuity, none of which had worse than counting fingers in one eye, 1 had glaucoma coexisting with diabetic maculopathy, 5 were too sick to participate, 2 had moved out of the region, and 1 set of case notes was missing). Eighty-four patients were therefore eligible. Nineteen patients had had Esterman fields previously (none has had further laser since the field was performed) and 65 patients were All the patients who declined to attend the visual field test claimed to be non-drivers on questioning. Table 1 summarises the treatment parameters of those patients who did and did not perform the field test. There was no significant difference in any of the parameters between the two groups on unpaired two-tailed t-test at a significance level of p = 0.05. Sixty-three of the 64 patients who took the Esterman test passed, with 4 of those who passed requiring a second test due to a missing single point on the first test.
The one patient who failed was later identified to have a relatively mild homonymous hemianopic defect. He had passed on the points in the central 20° of fixation where misses would be expected to occur when secondary to laser therapy (Fig. 1) .
Discussion
The importance of a good binocular visual field in the context of driving has been previously documented? Constriction of this field can cause reduced ability to identify road signs and avoid obstacles, and can increase the time needed to complete a driving course? To date there has been no published literature on the effects of isolated paracentral scotomata on driving, but these may be used by the DVLA as a reason for failure.s There is well-documented evidence of loss of uniocular visual field after bilateral PRP in diabetics.s-1 2 High energy used during coagulation may cause more visual field losses. 1 2 A number of studies have been performed with respect to binocular fields (according to DVLA criteria) following PRP, with one study recording a 50% failure rate of the DVLA regulations.4 Interestingly 2 patients who failed had only had unilateral PRP, and the failure was attributed to field losses unrelated to laser treatment. Other studies have shown that bilateral PRP can lead to a much lower frequency of DVLA field failure, particularly when smaller spot sizes are used. 6 • 13 More recently, it has been suggested that a 12% failure rate may be expected after bilateral PRP, the risk being greater in type II diabetics.lO In addition, there may be substantial differences in the assessment of driving fields between consultants and the Visual Standards Sub-committee (VSSC), with more cases passing when the fields were assessed by the VSSc. 9 Previous studies have documented a decrease in retinal sensitivity after laser treatment of the macula when uni-ocular fields were assessed. Central 30° visual field sensitivity has been noted to decrease after diode, YAG and krypton laser treatment in diabetics with maculopathy. 1 4 Perifoveal laser treatment of the macula for subretinal membranes can lead to relative scotomata which increase in depth over time. IS However, this type of treatment is usually designed to be confluent in nature and this effect may not be clinically relevant following commonly used diabetic maculopathy treatment strategies.
Diabetic retinopathy itself may lead to uni-ocular visual field losses. 16 Using a moving target at a distance of 1 m, scotomata subtending half a degree angle can be identified. Relative scotomata were observed in diabetics with little or no retinopathy and absolute scotomata in There is, however, no evidence in the literature that retinopathy per se can lead to significant losses (in this context) in the binocular visual field, as defects in one eye tend to be compensated by a normal field in the other.
Other possible reasons for visual field losses in patients with primary diabetes mellitus include older age, cataracts,20 age-related macular degeneration,2 1 ,22 glaucoma,2 3 optic neuropathy and acute hypoglycaemia?4 We only excluded known cases of glaucoma in our study, thereby including the vast majority of those currently taking the DVLA test following bilateral macular laser therapy.
As many patients in the UK undergo bilateral macular laser without PRP, the performance of driving visual fields on all these patients represents a significant use of resources. Time and manpower are required to order, perform and process the results of the tests. Although not formally measured, much anxiety is also engendered in those instructed to undergo the test procedure, as failure may have significant effects on lifestyle.
The results of this study suggest that binocular visual fields may not need to be a routine part of the assessment of patients who drive and who have had bilateral laser treatment for diabetic maculopathy. Further studies will be necessary to determine whether the test should be performed in patients who have theoretical risk factors for failing the test, i.e. those blind in one eye and those who have had very extensive treatment where the number, size of burn and confluency differ significantly from those found in our study. However, at present, patients similar to those studied may be counselled with some confidence that their chances of failing the DVLA field test are very low.
